Objective: Statins and hormone therapy (HT), often used concurrently in postmenopausal women, have antagonist effects on the risk of venous thromboembolism (VTE). Methods: We conducted a nested case-control study within a population-based cohort of women aged 50–79 years between January 1, 1987 and March 1, 2008, who were identified from the UK General Practice Research Database.
READ FULL ARTICLE
From Lww